Olympus Corporations’ Odin Medical receives US FDA clearance for first cloud-based AI endoscopy system for colonoscopy
Posted:
Odin Medical, an Olympus Corporation company, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the first cloud-based AI technology designed to assist gastroenterologists in detecting suspected colorectal polyps during colonoscopy procedures, the CADDIE computer-aided detection (CADe) device.
Buckinghamshire Healthcare NHS Trust has become the first NHS organisation to sign a contract with System C to implement its CareFlow Ambient AI Outpatient Consultations module, with go-live planned for Summer 2026.
Read more here.
Whole-body diffusion-weighted MRI (WB-DWI/MRI) after neoadjuvant chemotherapy (NACT) predicted complete resection at interval debulking surgery (IDS) with more than 93% accuracy in patients with advanced ovarian cancer while demonstrating superior performance over CT.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us